Crizanlizumab vs Warfarin

Crizanlizumab vs Warfarin: Overview

This comparison examines the pharmacological differences between Crizanlizumab and Warfarin.

Mechanism of Action

Warfarin: Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics

Half-life: Warfarin — 20-60 hours.

Chemical Properties

Molecular Formula: Warfarin — C19H16O4.

Molecular Weight: Warfarin — 308.3280 g/mol.

Type: Crizanlizumab — Antibody; Warfarin — Small molecule.